asp-1001
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2010 (NCT00791102)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetContrast agent
contrast agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- asp-1001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00791102 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2010 | Asphelia Pharmaceuticals, University of Chicago |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asphelia Pharmaceuticals | For profit | 1 | 0 | 1 | 2010 |
| University of Chicago | Academic/Hospital | 1 | 1 | 1 | 2010 |
2 organizations
Page 1 / 1